BMO Capital Maintains Outperform on Nutrien, Raises Price Target to $90

BMO Capital analyst Joel Jackson has maintained an Outperform rating on Nutrien (NYSE: NTR) and raised the price target from $85 to $90. This adjustment reflects a positive outlook for the company's performance in the market.